statistiche ricercatore

Continente	#
AS - Asia	1.116
NA - Nord America	1.074
EU - Europa	859
SA - Sud America	129
Continente sconosciuto - Info sul continente non disponibili	52
AF - Africa	30
OC - Oceania	23
Totale	3.283

Nazione	#
US - Stati Uniti d'America	1.024
IT - Italia	394
SG - Singapore	292
CN - Cina	202
VN - Vietnam	161
HK - Hong Kong	115
DE - Germania	103
RU - Federazione Russa	102
BR - Brasile	98
GB - Regno Unito	63
IN - India	61
KR - Corea	48
BD - Bangladesh	47
FR - Francia	35
ID - Indonesia	30
JP - Giappone	29
CA - Canada	28
NL - Olanda	26
FI - Finlandia	22
AU - Australia	21
MY - Malesia	21
ES - Italia	19
IE - Irlanda	19
TR - Turchia	19
PK - Pakistan	17
IR - Iran	16
BE - Belgio	14
IQ - Iraq	14
MX - Messico	14
PL - Polonia	14
ZA - Sudafrica	12
DK - Danimarca	11
AR - Argentina	10
PH - Filippine	6
SE - Svezia	6
TW - Taiwan	6
UZ - Uzbekistan	6
CO - Colombia	5
EC - Ecuador	5
NO - Norvegia	5
SA - Arabia Saudita	5
TN - Tunisia	5
AT - Austria	4
CR - Costa Rica	4
EG - Egitto	4
NP - Nepal	4
UA - Ucraina	4
VE - Venezuela	4
BY - Bielorussia	3
CL - Cile	3
IL - Israele	3
LT - Lituania	3
MA - Marocco	3
PT - Portogallo	3
AE - Emirati Arabi Uniti	2
AZ - Azerbaigian	2
GR - Grecia	2
HU - Ungheria	2
JO - Giordania	2
LB - Libano	2
NZ - Nuova Zelanda	2
PY - Paraguay	2
AG - Antigua e Barbuda	1
AL - Albania	1
AM - Armenia	1
BB - Barbados	1
BJ - Benin	1
CH - Svizzera	1
ET - Etiopia	1
GH - Ghana	1
GT - Guatemala	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
KZ - Kazakistan	1
MK - Macedonia	1
MO - Macao, regione amministrativa speciale della Cina	1
MT - Malta	1
MU - Mauritius	1
NG - Nigeria	1
NI - Nicaragua	1
PE - Perù	1
SI - Slovenia	1
TH - Thailandia	1
UY - Uruguay	1
Totale	3.231

Nome	#
Development of New Toll-Like Receptor 4-directed adjuvants and Clarification of their Mechanism of Action	480
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants	451
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists	410
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants	303
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases	296
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists	277
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies	255
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity	235
A Global Picture of Molecular Changes Associated to LPS Treatment in THP-1 Derived Human Macrophages by Fourier Transform Infrared Microspectroscopy	227
Use of Fluorescent Chemical Probes in the Study of Toll-like Receptors (TLRs) Trafficking	191
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases	147
Design and synthesis of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy	11
Totale	3.283

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	91	0	0	9	11	10	7	7	8	5	8	9	17
2022/2023	124	17	16	10	10	14	9	2	6	5	21	8	6
2023/2024	260	1	6	18	13	13	16	21	38	36	35	26	37
2024/2025	892	43	49	76	48	70	54	46	42	70	118	80	196
2025/2026	1.653	195	97	125	214	175	78	225	56	111	159	82	136
2026/2027	161	73	52	36	0	0	0	0	0	0	0	0	0
Totale													3.283

Bicocca Open Archive